Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center (MAEva-pro)

December 19, 2025 updated by: Institut de Cancérologie de Lorraine

The MAEva program seems to meet the challenges of implementing meditation for cancer care workers. As part of our Quality of Life and Working Conditions initiative, the investigator decided to offer it to staff at our Cancer Center. The MAEva program is delivered in a closed format: participants commit to following, as far as possible, the three sessions of the program - one session per week for 3 weeks. During the sessions, it will be proposed to train meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.

Before and after the program, participants will complete a quality of life evaluation, a perceived stress scale, and a questionnaire to assess psychological flexibility.

At the end of the program, each participant will be asked to complete a satisfaction questionnaire and a semi-directive interview, by videoconference, or by telephone in the event of digital impossibility with voice recording, to enable a qualitative analysis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Vandœuvre-lès-Nancy, France, 54519
        • Institut de Cancérologie de Lorraine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participant of legal age
  • Willingness to participate in the program - voluntary registration
  • Commitment to attend all 3 program sessions
  • Schedule compatible with participation in the 3 program sessions
  • Participant has understood, signed and dated the consent form
  • Participant affiliated to the social security system

Exclusion Criteria:

  • No desire to participate in the program - non-registration
  • Previous participation in MAEva program
  • No commitment to participate in the 3 program sessions
  • Agenda incompatible with the 3 program sessions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MAEva program is delivered in a closed format
MAEva program is delivered in a closed format. One session per week for 3 weeks.
Other: Mindfulness closed program
MAEva program will be proposed with meditative practices and three different themes will be addressed (one theme per session): Meditation, Acceptance and Commitment to values.
Diagnostic test: Quality of life evaluation
The assessment will be carried out at inclusion and after completion of the program.
Diagnostic test: Perceived Stress Scale
The assessment will be carried out at inclusion and after completion of the program.
Diagnostic test: Multidimensional Psychological Flexibility Inventory
The assessment will be carried out at inclusion and after completion of the program.
Other: satisfaction questionnaire and semi-structured interview
The assessments will be carried out after completion of the program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the feasibility and acceptability of the MAEva program among employees at a hospital (CLCC: Centre de Lutte Contre le Cancer or Cancer Center).
Time Frame: 5 weeks
Participation rate of employees at a hospital in the MAEva program and number of sessions attended (number of participants who completed the entire program)
5 weeks
Evaluate the feasibility and acceptability of the MAEva program among employees at a hospital (CLCC: Centre de Lutte Contre le Cancer or Cancer Center).
Time Frame: 5 weeks
Number of sessions attended (number of participants who completed the entire program)
5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.
Time Frame: 5 weeks
Quality of working life assessment (subjective score between 1 and 10 on the Quality of Working Life Scale)
5 weeks
Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.
Time Frame: 5 weeks
Stress assessment (Perceived Stress Scale - PSS-10)
5 weeks
Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.
Time Frame: 5 weeks
Assessment of psychological flexibility (Multidimensional Inventory of Psychological Flexibility (MPFI-24))
5 weeks
Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.
Time Frame: 5 weeks
Assessment of participant satisfaction (subjective score between 1 and 10; open-ended questions (qualitative analysis))
5 weeks
Evaluate the initial effectiveness of the MAEva program on the well-being of employees at a hospital.
Time Frame: 5 weeks
Assessment of processes at play during the intervention (semi-structured interviews (qualitative analysis))
5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Institut de Cancérologie de Lorraine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2025

Primary Completion (Actual)

April 30, 2025

Study Completion (Actual)

September 13, 2025

Study Registration Dates

First Submitted

March 13, 2025

First Submitted That Met QC Criteria

March 24, 2025

First Posted (Actual)

March 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2024-A02765-42

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Employees at a Hospital

Clinical Trials on Mindfulness closed program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe